Hong Kong Rentai Medical Pharmacy Limited is a business entity registered in the Hong Kong Special Administrative Region of the People's Republic of China. Incorporated on 08-03-2022, it is a Private company limited by shares and its former company registration number was 3133141.
Since 27-12-2023, The Government of the Hong Kong SAR has been using Business Registration Number (BRN) as unique identifier for business entities in Hong Kong. The 8-digit business registration number for Hong Kong Rentai Medical Pharmacy Limited is C3133141.
The registration address of Hong Kong Rentai Medical Pharmacy Limited is RM. 517, NEW CITY CENTRE, 2 LEI YUE MUN ROAD, KWUN TONG, KLN, HONG KONG. According to open business data, the registration status of this company is DEREGISTERED
香港仁太醫大藥房有限公司是一家於中華人民共和國香港特別行政區註冊的私人股份有限公司。 它成立於 08-03-2022,公司註冊號碼是 3133141。
自2023年12月27日起,香港特別行政區政府使用商業登記號碼(BRN)作為香港商業實體的唯一識別碼。香港仁太醫大藥房有限公司 的 8 位商業登記號碼是 C3133141。
香港仁太醫大藥房有限公司的公司註冊地址為 RM. 517, NEW CITY CENTRE, 2 LEI YUE MUN ROAD, KWUN TONG, KLN, HONG KONG 。根據公開資料,它的註冊狀況是 已撤銷
Our AI model infers that Hong Kong Rentai Medical Pharmacy Limited has a high probability of participation in the business sector of pharmacies and medicine companies.
根據我們的人工智能模型推演,香港仁太醫大藥房有限公司有較高的機率從事 藥房和醫藥公司 業務。
The above profile is compiled with data available from public domains. This is not an official webpage of the aforesaid company.
Chief Executive John Lee started his visit programme to Lima, Peru.
Yesterday, he received President Xi Jinping who...
Secretary for Commerce & Economic Development Algernon Yau attended the 35th Asia-Pacific Economic Cooperation (APEC...
The Government today announced the launch of a retail infrastructure bond for subscription by Hong Kong residents....
Hong Kong ranks seventh globally in the latest World Digital Competitiveness Ranking (WDCR) 2024 published by the Interna...
Secretary for Innovation, Technology & Industry Prof Sun Dong and Vice Minister of Science & Technology Lin Xin c...
(To watch the full media session with sign language interpretation, click here.)
Chief Executive John Lee to...